ARTICLE | Clinical News
FDA grants TLC178 rare pediatric disease designation
May 4, 2017 4:05 PM UTC
FDA granted rare pediatric disease designation to TLC178 from Taiwan Liposome Co. Ltd. (TPEx:4152) to treat rhabdomyosarcoma. The liposomal encapsulated formulation of vinorelbine has Orphan Drug des...
BCIQ Company Profiles
BCIQ Target Profiles